Key result
Emergent norovirus GII.P16-GII.2 variant targets ~5-fold more older children and adults than pandemic GII.4 strains.
Observational (n=393)
No
Absolute Event Rate: 44% vs 9%
p-value: p=<0.0001
The emergent recombinant norovirus GII.P16-GII.2 strain targets a wider age population, including young adults, compared to circulating pandemic GII.4 strains.
May expand norovirus risk to young adults; hypothesis-generating for updated surveillance and vaccines.
A new recombinant norovirus GII.P16-GII.2 outnumbered pandemic GII.4 as the predominant GII genotype in the winter of 2016-2017 in Hong Kong, China. Half of hospitalized case-patients were older children and adults, including 13 young adults. This emergent norovirus targets a wider age population compared with circulating pandemic GII.4 strains.
No takes yet. Share an insight, caveat, or question.
Kwok et al. (2017) conducted an observational in Acute gastroenteritis (n=393). Norovirus GII.P16-GII.2 vs. Norovirus GII.4 was evaluated on Proportion of older children and adults (5-65 years of age) (p=<0.0001). The emergent recombinant norovirus GII.P16-GII.2 variant targeted a significantly higher proportion of older children and adults (5-65 years) compared to circulating pandemic GII.4 strains (44% vs 9%, p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: